Jordi Minguillon
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.
Journal: Leukemia
Published: March 11, 2026
Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.
Journal: Molecular therapy. Oncology
Published: April 17, 2025
CD19 CAR-T cell therapy in a pediatric patient with MDA5+ dermatomyositis and rapidly progressive interstitial lung disease.
Journal: Med (New York, N.Y.)
Published: February 10, 2025
Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults.
Journal: Experimental hematology & oncology
Published: December 18, 2024
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.
Journal: Journal of hematology & oncology
Published: November 05, 2024
Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment.
Journal: Pharmacological research
Published: October 16, 2024
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.
Journal: American journal of hematology
Published: July 24, 2024
Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations.
Journal: Frontiers in immunology
Published: February 16, 2024
Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
Journal: Oral oncology
Published: June 22, 2022
Last Updated: 09/26/2026